PLA2G2D and chronic obstructive pulmonary disease: sPLA2s are secreted at low levels in normal airways, and they tend to increase during inflammatory lung diseases (e.g., bronchial asthma, chronic obstructive pulmonary disease, interstitial lung fibrosis, and sarcoidosis) as the result of plasma extravasation and/or local production.